Superior efficacy of nilotinib vs imatinib in patients with chronic myeloid leukemia in chronic phase. ENESTnd and ENESTcmr current results analysis Journal title: OncoReview Authors: Tomasz Sacha Subject(s): Medicine, Cardiology, Internal Medicine, Oncology, Cardiac & Cardiovascular Systems
Większa skuteczność nilotynibu niż imatynibu w leczeniu przewlekłej białaczki szpikowej w fazie przewlekłej. Analiza aktualnych wyników badania ENESTnd i ENESTcmr Journal title: OncoReview Authors: Tomasz Sacha Subject(s): Medicine, Cardiology, Internal Medicine, Oncology, Cardiac & Cardiovascular Systems
Inhibitory kinazy tyrozynowej w rozrostowych chorobach układu krwiotwórczego Journal title: Advances in Hygiene and Experimental Medicine Authors: Kamila Kosior, Magdalena Lewandowska-Grygiel, Krzysztof Giannopoulos Subject(s): Medicine
Tyrosine kinase inhibitors in hematological malignancies Journal title: Advances in Hygiene and Experimental Medicine Authors: Kamila Kosior, Magdalena Lewandowska-Grygiel, Krzysztof Giannopoulos Subject(s): Medicine
Targeted therapies for chronic myeloid leukemia and cardiovascular system Journal title: OncoReview Authors: Sebastian Szmit, Wiesław Jędrzejczak, Adam Torbicki Subject(s): Medicine, Cardiology, Internal Medicine, Oncology, Cardiac & Cardiovascular Systems
Molecular genetic and cytogenetic determinants of primary resistance or loss of the response to treatment with tyrosine kinase inhibitors in patients with chronic myeloid leukemia Journal title: Медичні перспективи Authors: K. Kotlyarchuk, Z. Maslyak, A. Lukianova, O. Tsyapka , I. Selina, H. Usenko Subject(s):
Molecular genetic and cytogenetic determinants of primary resistance or loss of the response to treatment with tyrosine kinase inhibitors in patients with chronic myeloid leukemia Journal title: Медичні перспективи Authors: K. Kotlyarchuk, Z. Maslyak, A. Lukianova, O. Tsyapka , I. Selina, H. Usenko Subject(s):
DEVELOPMENT AND VALIDATION OF METHOD FOR THE DETERMINATION OF NILOTINIB BY RP-HPLC IN BULK AND PHARMACEUTICAL DOSAGE FORMS Journal title: International Research Journal of Pharmacy (IRJP) Authors: Harika Myneni , G.S. Kumar Subject(s):
Молекулярно-генетичні та цитогенетичні детермінанти первинної резистентності або втрати відповіді на лікування інгібіторами тирозинкінази хворих на хронічну мієлоїдну лейкемію Journal title: Медичні перспективи Authors: K. Kotlyarchuk, Z. Maslyak, A. Lukianova, O. Tsyapka , I. Selina, H. Usenko Subject(s):
Gonadotoxic Effects of Nilotinib in Chronic Myeloid Leukemia Treatment Dose in a Mouse Model Journal title: Turkish Journal of Hematology Authors: Güldane Cengiz Seval, Sinan Özkavukçu, Murat Seval, Meltem Aylı Subject(s):
Assessment of Quality of Life of Chronic Myeloid Leukemia Patients by Using the EORTC QLQ-C30 Journal title: Turkish Journal of Hematology Authors: Mehmet Can Uğur, Yaşar Bekir Kutbay, Özge Özer Kaya, Cengiz Ceylan Subject(s):
Imatinib-Induced Interstitial Pneumonitis Successfully Switched to Nilotinib in a Patient with Prior History of Mycobacterium tuberculosis Infection Journal title: Turkish Journal of Hematology Authors: Zhuan-Bo Luo, Ning Xu, Xiao-Ping Huang, Gui-fang Ouyang Subject(s):
Nilotinib induced skin rash in chronic myeloid leukemia patients: A case series Journal title: International Journal of Medical Science and Public Health Authors: Nilesh Wasekar, Aniket B Mohite, Chandrakala S, Vinod P, Rajesh P, Shailesh B, Farah Jijina Subject(s):
Myocardial Infarction in a Young Patient with Chronic Myeloid Leukemia after Nilotinib Use Journal title: International Journal of Medical and Pharmaceutical Case Reports Authors: Neila Fathallah, Kmira Zahra, Rania Bouneb, Mohamed Mahjoub, Wafa Guetari, Monia Zaier, Chaker Ben S... Subject(s):
DEVELOPMENT AND VALIDATION OF A STABILITY INDICATING HPLC METHOD FOR THE DETERMINATION OF NILOTINIB HYDROCHLORIDE IN BULK AND PHARMACEUTICAL DOSAGE FORM Journal title: International Journal of Pharmacy and Pharmaceutical Sciences Authors: Ramu Ivaturi, T. Manikya Sastry, S. Satyaveni Subject(s):
